Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.More On These Topics From The Pink Sheet Artificial Intelligence: CDER’s New Council Takes Char…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
13:48
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people reco…
…
continue reading
Interest in the human gut microbiome and the influence it exerts on a person’s wellbeing, from cognitive health to immunity, has been rapidly increasing in recent years. In this episode of HBW Insight's Over the Counter podcast we speak to Dublin-based food company Kerry Group about a particularly exciting, emerging area of microbiome-based wellnes…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal better than expected?; new diabetes risk data for Zepbound; can J&J’s lung cancer combo stand up to Tagrisso?; new recruits for BioMarin leadership; and Glenmark’s shifting revenues.https://scrip.citeline.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
15:22
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcas…
…
continue reading
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).Citeline
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
…
continue reading
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
…
continue reading
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらWhat To Look Out For At ESC 2024https://scrip.citeline.com/SC150740/What-To-Look-Out-For-At-ESC-2024Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
29:47
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has made it a mission to be a leader in thought and actions in meeting Scope 1, 2 and 3 needs. Corporate VP and head of sustainability Meron Mathias explains the company's sustainability aims and methods, f…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesity and diabetes; BMS returns TIGIT asset in pipeline reshuffle; is Kerendia the next jewel in Bayer’s crown?; Japan pharma firms cut jobs; and Sun Pharma seeks GLP-1 partner.https://scrip.citeline.com…
…
continue reading
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s oral health. In this episode of Over the Counter, HBW Insight catches up with Haleon vice president and general manager Great Britain and Ireland Bas Vorsteveld, to find out more about why having a purpo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
33:10
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), questions about approving a new drug that would be used with a standard of care regimen that is off-label (15:00), and the agency beginning to schedule fully in-person advisory committee meetings (24:03…
…
continue reading
In this audio, Dr. Anthony Fritz discusses Type 2 diabetes and the benefits of SGLT2 inhibitors. Learn how this treatment option can improve diabetes care.Citeline
…
continue reading
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장 큰 폭으로 하락했습니다. Scrip의 글로벌 제약주 동향 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150593/Obesity-Rules-Large-Cap-Stocks-In-First-Half-Of-2024Citeline
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its oral GLP-1; BMS’s rising confidence about Medicare pricing of Eliquis; more long term data for Leqembi; NewAmsterdam’s CETP inhibitor shows promise; and a look at Mankind’s Bharat Serums buy.https://scri…
…
continue reading
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare BMS’ Opdivo along with AstraZeneca’s Imfinzi (10:11), and the EMA potentially asking all sponsors to provide raw clinical data as part of application reviews (33:14).More On These Topics From The Pink…
…
continue reading
RNK Pharma founder and CEO Yaning Wang joins Brian Yang to discuss Shanghai's latest biopharma stimulus policies and the globalization of China biotech. Dexter Yan also discusses China biotech initial public offerings in the first half of this year.Citeline
…
continue reading
COPD expert Wen-Yu discusses what the entrance of biologics might mean for the COPD treatment landscape and shares a sneak peek from her upcoming patient-based forecast.Other platforms (in addition to SoundCloud):Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.goo…
…
continue reading
Join us for an insightful Q&A session on the treatment of multiple myeloma with Oncologist Dr. Joshua Richter. In this video, Dr. Richter shares his expert knowledge on the latest advancements, treatment options, and patient care strategies for multiple myeloma.Citeline
…
continue reading
Consumers are expecting more and more from health and wellness brands, PA Consulting’s latest Brand Impact Index shows. Consumer health brands that link wellness to the sanctuary of the home do particularly well, explains PA consumer product expert Rhea Patten, on the latest episode of HBW Insight’s Over the Counter podcast. But do consumers expect…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 July 2024. In this episode: Narasimhan plays the long game; Merck & Co’s RSV contender; Mounjaro’s China approval; the mid-cap rising stars; and AI could add billions in drug revenues.https://scrip.citeline.com/SC150656/Quick-Listen-Scrips-Five-MustKnow-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
27:09
Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren (:35), PBM executives again appearing unscathed after another Capitol Hill appearance (10:12), and the growing push to ensure the FDA’s rare pediatric disease priority review voucher program is renewed (20:41).More On These Topics From The Pink SheetShuren Steps D…
…
continue reading
Join Victoria Bradley and Dr. Andrew Freeman as they discuss the latest advancements in heart failure treatment, from innovative therapies to the role of AI and personalized medicine. Discover how technology is revolutionizing patient care, ensuring patient safety, and improving outcomes.Citeline
…
continue reading
This Q&A session emphasizes early diagnosis of COPD for better lung function preservation and disease control. It explores COPD symptoms, diagnosis tools, treatment options, and the importance of lifestyle changes, especially smoking cessation.Citeline
…
continue reading
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview with Motif Neurotech's CEO Jacob Robinson. Elizabeth Orr discusses DeepWell DTx's newly launched VR game for treating stress-related hypertension and anxiety. Natasha Barrow provides an overview of Digital M…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track for blockbuster status; US uptake of Rezzdifra held up by payers; CNS drugs are surprisingly valuable; obesity rules large cap stocks; and Legend buyout rumors validate China biotech.https://scrip.citel…
…
continue reading
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global uses AI to help device manufacturers navigate global regulations, and we talk about clinical trials, how countries incentivize medtech innovation, and the Biden Administration’s tariffs on some Chinese…
…
continue reading
Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first, including most new cell and gene therapies and cancer treatments.More On This Topics From The Pink SheetPharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals: htt…
…
continue reading
신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI 신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경쟁에서 살아남기 위해 국내업계가 해야 할 일에 대해 이야기했습니다.https://scrip.citeline.com/SC150336/Korea-Looks-To-Close-Gap-In-AI-Drug-Development-CapabilitiesCiteline
…
continue reading
Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Chandler Walker, Product Manager of Digital PCR Instruments at Thermo Fisher Scientific and Janelle Hart, managing editor at Citeline.Citeline
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfizer’s R&D leadership succession; Lilly bolsters IBD pipeline; first half deal volume up but value down; and EU firms’ China sentiment plummets.https://scrip.citeline.com/SC150587/Quick-Listen-Scrips-Five-…
…
continue reading
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading
Improving Communication: The Relationship Between Biotech And Biopharma by CitelineCiteline
…
continue reading
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「US FDA’s Cell-Gene Therapy Office Head Wants Sponsors To Seek Out Meetings( 邦題意訳:米国FDAの細胞遺伝子治療室長「もっと面談を」企業に求める理由は)」 (英語版)https://pink.citeline.com/PS154749/US-FDAs-Cell-Gene-Therapy-Office-Head-Wants-Sponsors-To-Seek-Out-Meetings※全文の…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s Alzheimer's contender; the challenges and rewards of late-stage ADCs; Eisai regains control of ADC from BMS; RSV vaccine developers hit by declining expectations; and an interview with Amgen’s Ian Thomps…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
48:19
Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June a…
…
continue reading
In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products for use by clinicians, biopharma companies and researchers.Citeline
…
continue reading
In Vivo Podcast Episode with Stefan Woxström by CitelineCiteline
…
continue reading
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and hea…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.https://scrip.citeline.com/SC150517/Quick-L…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
35:29
Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what was left out (:35), as well as an upcoming guidance on the use of artificial intelligence in regulatory decision-making (27:30).More On These Topics From The Pink SheetDiversity Action Plans Should Be …
…
continue reading
Guest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotechs' Hutchmed, Jiangsu Hengrui and Innovbent Bio’s clinical data readouts at the recent EHA and ADA annual meetings.https://scrip.citeline.com/SC150487/China-Biotech-Podcast-EHAADAPlaylist: https://soundcl…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launches; Merck confident in new pneumococcal vaccine; multiple US setbacks for Japanese firms; Stock Watch on Moderna missteps; and Sun’s North America head talks plans and strategy.https://scrip.citeline…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
26:24
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
35:21
In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a series of painfully honest conversations they had about their hormonal and emotional challenges,” The SABI markets a range of herbal infusions aimed at alleviating some of the impacts of painful periods a…
…
continue reading
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; biopharma funding on an upswing?; Moderna’s combo jab; clinical trial recover from pandemic; and Astellas’s US commercial head speaks. https://scrip.citeline.com/SC150442/Quick-Listen-Scrips-Five-Must…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
22:44
In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.Talent acquis…
…
continue reading
The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 2024 conference.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS…
…
continue reading
Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, updates to the planned US BIOSECURE Act and industry preparations for its impact. Dexter also discusses China biotech's data highlights from ASCO 2024.https://scrip.citeline.com/SC150438/China-Biotech-P…
…
continue reading